The transcription factor RBPJ is required for inflammatory macrophage activation in thoracic aortic dissection by mediating mechanotransduction-induced glycolysis.

转录因子 RBPJ 通过介导机械转导诱导的糖酵解,在胸主动脉夹层中激活炎症巨噬细胞。

阅读:2
Abnormal infiltration and activation of monocyte-derived macrophages (moMFs) contribute significantly to thoracic aortic dissection (TAD). The transcription factor RBPJ mediates canonical Notch signaling and modulates macrophage activation, but the role and mechanism of RBPJ in macrophages in TAD remains unclear. Here, we show that RBPJ was upregulated in macrophages infiltrating the aorta in TAD patients and BAPN-induced mouse model. Myeloid-specific Rbpj ablation protected mice from TAD, reducing death, aortic damage, macrophage infiltration, and M1-like polarization while enhancing M2-like polarization. Because moMFs dominate aorta as shown in public scRNA-seq data, and RBPJ is upregulated in moMFs compared with blood monocytes/macrophages, we assumed that mechanical force, specifically cyclic stretch, might be one of the environmental cues of macrophage activation in aorta. Indeed, bone marrow-derived macrophages (BMDMs) loaded with cyclic stretch upregulated RBPJ expression in a Piezo1-dependent way, accompanied by increased M1-like polarization, and Rbpj ablation cancelled the force-induced M1-like polarization. By RNA-sequencing, we found that cyclic stretch induced a metabolic reprogram of BMDMs characterized by upregulation of glycolysis-related genes and HIF1α, which was dependent on RBPJ. Further analyses showed that cyclic stretch upregulated PDK1, a negative regulator of pyruvate dehydrogenase (PDH), which was abrogated by RBPJ deficiency. Based on these findings, we administered dichloroacetate (DCA), a pan-PDK inhibitor, in TAD mice, and found that DCA significantly attenuated BAPN-induced TAD in mice. Therefore, our results demonstrate that RBPJ is required for pro-inflammatory moMFs activation, likely by mediating mechanotransduction-induced glycolysis via PDK1 upregulation, and PDK1 inhibitors such as DCA are potential therapeutics for TAD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。